237 related articles for article (PubMed ID: 17383068)
1. Inhibitory action of polyunsaturated fatty acids on IMP dehydrogenase.
Mizushina Y; Dairaku I; Yanaka N; Takeuchi T; Ishimaru C; Sugawara F; Yoshida H; Kato N
Biochimie; 2007 May; 89(5):581-90. PubMed ID: 17383068
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory action of polyunsaturated fatty acids on Cdt1-geminin interaction.
Mizushina Y; Takeuchi T; Takakusagi Y; Sugawara F; Sakaguchi K; Yoshida H; Fujita M
Int J Mol Med; 2008 Mar; 21(3):281-90. PubMed ID: 18288374
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of telomerase by linear-chain fatty acids: a structural analysis.
Oda M; Ueno T; Kasai N; Takahashi H; Yoshida H; Sugawara F; Sakaguchi K; Hayashi H; Mizushina Y
Biochem J; 2002 Oct; 367(Pt 2):329-34. PubMed ID: 12121150
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
[TBL] [Abstract][Full Text] [Related]
5. Effects of cis-unsaturated free fatty acids on PKC-epsilon activation and nicotinic ACh receptor responses.
Yaguchi T; Yamamoto S; Nagata T; Kanno T; Tanaka A; Nishizaki T
Brain Res Mol Brain Res; 2005 Feb; 133(2):320-4. PubMed ID: 15710250
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.
Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M
Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342
[TBL] [Abstract][Full Text] [Related]
7. Acid-base catalysis in the chemical mechanism of inosine monophosphate dehydrogenase.
Markham GD; Bock CL; Schalk-Hihi C
Biochemistry; 1999 Apr; 38(14):4433-40. PubMed ID: 10194364
[TBL] [Abstract][Full Text] [Related]
8. A potent "fat base" nucleotide inhibitor of IMP dehydrogenase.
Wang W; Hedstrom L
Biochemistry; 1998 Aug; 37(34):11949-52. PubMed ID: 9718319
[TBL] [Abstract][Full Text] [Related]
9. Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain.
Felczak K; Chen L; Wilson D; Williams J; Vince R; Petrelli R; Jayaram HN; Kusumanchi P; Kumar M; Pankiewicz KW
Bioorg Med Chem; 2011 Mar; 19(5):1594-605. PubMed ID: 21324702
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of unsaturated long chain fatty acids in relation to the inhibition of gastric H+,K(+)-ATPase.
Murakami S; Muramatsu M; Araki H; Otomo S
Res Commun Mol Pathol Pharmacol; 1994 Jul; 85(1):57-66. PubMed ID: 7953195
[TBL] [Abstract][Full Text] [Related]
11. Phosphonic acid-containing analogues of mycophenolic acid as inhibitors of IMPDH.
Watkins WJ; Chen JM; Cho A; Chong L; Collins N; Fardis M; Huang W; Hung M; Kirschberg T; Lee WA; Liu X; Thomas W; Xu J; Zeynalzadegan A; Zhang J
Bioorg Med Chem Lett; 2006 Jul; 16(13):3479-83. PubMed ID: 16621550
[TBL] [Abstract][Full Text] [Related]
12. Novel indole inhibitors of IMPDH from fragments: synthesis and initial structure-activity relationships.
Beevers RE; Buckley GM; Davies N; Fraser JL; Galvin FC; Hannah DR; Haughan AF; Jenkins K; Mack SR; Pitt WR; Ratcliffe AJ; Richard MD; Sabin V; Sharpe A; Williams SC
Bioorg Med Chem Lett; 2006 May; 16(9):2539-42. PubMed ID: 16483773
[TBL] [Abstract][Full Text] [Related]
13. Computational insights into the inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid analogs: three-dimensional quantitative structure-activity relationship and molecular docking studies.
Yang N; Wang J; Wang ZW; Wang QH; Yang HG; Wang XJ; Cheng MS
Chem Biol Drug Des; 2012 Jun; 79(6):1063-71. PubMed ID: 22405057
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids.
Petitpas I; Grüne T; Bhattacharya AA; Curry S
J Mol Biol; 2001 Dec; 314(5):955-60. PubMed ID: 11743713
[TBL] [Abstract][Full Text] [Related]
15. The quality properties and saturated and unsaturated fatty acid profiles of quail egg: the alterations of fatty acids with process effects.
Tokuşoğlu O
Int J Food Sci Nutr; 2006; 57(7-8):537-45. PubMed ID: 17162332
[TBL] [Abstract][Full Text] [Related]
16. Effects of C18 fatty acids on breast carcinoma cells in culture.
Bégin ME; Ells G
Anticancer Res; 1987; 7(2):215-7. PubMed ID: 3592634
[TBL] [Abstract][Full Text] [Related]
17. Inosine 5'-monophosphate dehydrogenase inhibitors for the treatment of autoimmune diseases.
Ratcliffe AJ
Curr Opin Drug Discov Devel; 2006 Sep; 9(5):595-605. PubMed ID: 17002220
[TBL] [Abstract][Full Text] [Related]
18. Novel 7-methoxy-6-oxazol-5-yl-2,3-dihydro-1H-quinazolin-4-ones as IMPDH inhibitors.
Birch HL; Buckley GM; Davies N; Dyke HJ; Frost EJ; Gilbert PJ; Hannah DR; Haughan AF; Madigan MJ; Morgan T; Pitt WR; Ratcliffe AJ; Ray NC; Richard MD; Sharpe A; Taylor AJ; Whitworth JM; Williams SC
Bioorg Med Chem Lett; 2005 Dec; 15(23):5335-9. PubMed ID: 16202581
[TBL] [Abstract][Full Text] [Related]
19. Characterization of pharmacological efficacy of VX-148, a new, potent immunosuppressive inosine 5'-monophosphate dehydrogenase inhibitor.
Jain J; Almquist SJ; Heiser AD; Shlyakhter D; Leon E; Memmott C; Moody CS; Nimmesgern E; Decker C
J Pharmacol Exp Ther; 2002 Sep; 302(3):1272-7. PubMed ID: 12183689
[TBL] [Abstract][Full Text] [Related]
20. Monovalent cation activation in Escherichia coli inosine 5'-monophosphate dehydrogenase.
Kerr KM; Cahoon M; Bosco DA; Hedstrom L
Arch Biochem Biophys; 2000 Mar; 375(1):131-7. PubMed ID: 10683258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
